Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
(NASDAQ:DRTS),(NASDAQ:DRTSW), – Receipt of critical license marks significant milestone for first commercial-scale manufacturing facility for Alpha DaRT(R), the innovative alpha-radiation cancer therapy designed for potent and conformal tumor irradiation – – License paves way for introduction of radioactive material and continued positive momentum toward initiating Alpha DaRT treatment manufacturing in 2026 – JERUSALEM, Oct. 21, […]